In search of funds against the spread of coronavirus staff at the University of Washington School of Medicine in St. Louis found that the antidepressant fluvoxamine helps reduce the risk of severe Covid-19 and hospital admissions.
It is noted that they decided to study fluvoxamine, used to treat depression and obsessive-compulsive disorder, in the context of Covid-19 because it has strong anti-inflammatory properties: doctors suggested that the drug could prevent a cytokine storm – a powerful and sometimes deadly inflammatory response of the immune system for coronavirus and other pathogens.
The study involved 152 American adults (mean age 46; 109 of them were women) with PCR-confirmed coronavirus disease. At the start of the experiment, their symptoms were mild and had been present for about a week.
The subjects were randomly divided equally into two groups: the first took fluvoxamine for 15 days (50 milligrams in the evening on the first day, then 100 milligrams twice a day, and then the dose was increased to 100 milligrams three times a day), the second was given a placebo.
The results showed that none of the 76 patients in the first group had a worsening condition (oxygen saturation – 92% or lower, along with difficulty breathing or the development of pneumonia) compared with six (8.3 percent) participants in the placebo group. At the same time, four of them were hospitalized in the hospital for a period of four to 21 days. One patient was on mechanical ventilation for 10 days. Doctors did not record any lethal outcomes.
Thus, the authors of the work concluded, fluvoxamine can reduce the risk of worsening the condition of patients with Covid-19.
“The test results are encouraging. Fluvoxamine should be considered for treating Covid-19 patients in the early stages of the disease. Even when vaccines or other therapeutic agents are used as the first line of defense, fluvoxamine can dramatically reduce the risk of hospitalization. <…> Treatment that can prevent lung problems in people with coronavirus is urgently needed. We look forward to conducting a larger study in the coming weeks to further evaluate the effectiveness of fluvoxamine. “, – noted the researchers.
Earlier, “FACTS” wrote that in Germany, scientists have named a drink capable of destroying the coronavirus.